-+ 0.00%
-+ 0.00%
-+ 0.00%

POLYPID LTD - FDA AGREED TO A ROLLING NDA REVIEW, ALLOWING POLYPID TO SUBMIT FIRST COMPLETED SECTIONS IN EARLY 2026

Reuters·12/03/2025 13:30:00

Please log in to view news